Skip to main content
logo
Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.26
+0.17 (1.82%)
Sep 18, 2026, 4:08 PM HKT

Xuanzhu Biopharmaceutical Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
Market Capitalization
4,79436,515----
Market Cap Growth
------
Enterprise Value
4,20736,396----
Last Close Price
9.2670.50----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
PS Ratio
40.19633.81----
PB Ratio
3.2123.95----
P/TBV Ratio
6.7831.77----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
EV/Sales Ratio
35.27631.74----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
Debt / Equity Ratio
000.000.020.020
Net Debt / Equity Ratio
-0.39-0.48-0.26-0.39-0.68-0.71
Net Debt / EBITDA Ratio
2.933.170.461.373.024.29
Net Debt / FCF Ratio
-3.101.923.682.473.62
Asset Turnover
0.080.040.02---
Inventory Turnover
1.040.360.26---
Quick Ratio
2.733.041.453.2419.9514.26
Current Ratio
3.693.752.063.7921.2814.95
Return on Equity (ROE)
-19.61%-21.10%-53.84%--29.47%-16.87%
Return on Assets (ROA)
-9.68%-10.28%-27.99%--15.83%-14.54%
Return on Capital Employed (ROCE)
-15.10%-16.50%-55.40%-28.80%-23.00%-17.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '21 Dec '20
Earnings Yield
-5.06%-0.75%----
FCF Yield
--0.64%----
Buyback Yield / Dilution
-10.62%-3.15%--14.22%--